Physicochemical Properties
| Molecular Formula | C18H34O4 |
| Molecular Weight | 314.46016 |
| Exact Mass | 314.246 |
| CAS # | 627-86-1 |
| Related CAS # | 54406-23-4 |
| PubChem CID | 3093 |
| Appearance | Colorless to light yellow liquid |
| Density | 0.945g/cm3 |
| Boiling Point | 387.1ºC at 760 mmHg |
| Flash Point | 179.8ºC |
| Index of Refraction | 1.447 |
| LogP | 4.793 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 17 |
| Heavy Atom Count | 22 |
| Complexity | 248 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | CCCCCCCC(=O)OCCOC(=O)CCCCCCC |
| InChi Key | HTNFLUQQANUSLR-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C18H34O4/c1-3-5-7-9-11-13-17(19)21-15-16-22-18(20)14-12-10-8-6-4-2/h3-16H2,1-2H3 |
| Chemical Name | 2-octanoyloxyethyl octanoate |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Dioctanoylglycerol (dioctanoylglycerol) creates a longer-lasting diacylglycerol signal in platelets by inhibiting diacylglycerol phosphorylation (70–100% at 100 μM) [1]. |
| References |
[1]. Attenuation of sn-1,2-diacylglycerol second messengers by diacylglycerol kinase. Inhibition by diacylglycerol analogs in vitro and in human platelets. J Biol Chem. 1986 May 25;261(15):6993-7000. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~318.01 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (7.95 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 2.5 mg/mL (7.95 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (7.95 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.1801 mL | 15.9003 mL | 31.8005 mL | |
| 5 mM | 0.6360 mL | 3.1801 mL | 6.3601 mL | |
| 10 mM | 0.3180 mL | 1.5900 mL | 3.1801 mL |